[Indicators of cellular immunity in patients with multiple sclerosis].
As many as 111 patients with multiple sclerosis were subjected to clinical and functional examinations twice: on admission to the hospital and after immunocorrective therapy. The patients were discovered to have alterations in cellular immunity. During exacerbation, there was a decline of suppressors and a rise of the content of B lymphocytes. The immunocorrective therapy led to immunodeficiency stabilization.
Dziuba
A N
AN
Frolov
V M
VM
Gaĭdash
I S
IS
D000328:Adult; D001402:B-Lymphocytes / Q000276:immunology* / Q000473:pathology; D005260:Female; D006801:Humans; D007694:Killer Cells, Natural / Q000276:immunology / Q000473:pathology; D007958:Leukocyte Count; D008218:Lymphocytosis / Q000209:etiology* / Q000235:genetics; D008231:Lymphopenia / Q000209:etiology* / Q000235:genetics; D008297:Male; D008875:Middle Aged; D009103:Multiple Sclerosis / Q000235:genetics / Q000276:immunology*; D010641:Phenotype; D013601:T-Lymphocytes / Q000276:immunology* / Q000473:pathology; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology / Q000473:pathology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology / Q000473:pathology
Pokazateli kletochnogo immuniteta u bol'nykh rasseiannym sklerozom.